Phase
Condition
Alcohol Use Disorder
Addictions
Alcohol Dependence
Treatment
Placebo
Mavoglurant (AFQ056)
Clinical Study ID
Ages 18-45 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Ages 18-45 years
Estimated full-scale IQ>70
Individual can cooperate with all study procedures
No history of neurological disorder (e.g., epilepsy)
No major medical condition (e.g., cancer)
No history of significant head trauma
Stable medication treatment 6 weeks prior to study enrollment
Negative urine drug and breathe alcohol test at time of MRI scan
Negative urine pregnancy test at time of MRI scan
No MR contra-indications (e.g., in-body metal implant, severe claustrophobia)
No contra-indications to study drug
Exclusion
Exclusion Criteria:
A diagnosis of any psychotic disorder, or current mood or anxiety disorders underDSM-V, using the SCID-V-RV psychiatric interview
A current diagnosis of: a) Alcohol use disorder, if severe (AUD, mild or moderate OKif no craving, tolerance, and withdrawal 3 months prior to interview) b) Substanceuse disorder
Report of psychotic disorder in a 1º relative
Auditory or visual impairment that interferes with test-taking
Prenatal exposure to alcohol plus currently meeting criteria for features of fetalalcohol syndrome
Not speaking English fluently or being a non-native English speaker, or beingeducated in a primary language other than English > grade 1
Intellectual Disability (Full Scale IQ<70)
Traumatic brain injury with loss of consciousness > 30 minutes or concussion in last 30 days
Presence or history of neurosurgery or any neurologic illness that may affect brainphysiology (e.g., epilepsy, Multiple Sclerosis), including focal brain lesion seenon structural MRI (all structural scans are read by a board certified radiologist)
A current major medical condition (e.g. cancer, heart failure)
Current pregnancy (all females will be tested with urine screens on the day of MRI)
Women not on an effective form of birth control/contraception or abstinent duringtime of study visits to prevent exposure of the investigational drug to suspectedfetus
Current substance use with the exception of marijuana (THC), provided last use ofTHC was 24+ hours before visit (All participants will receive a urine screen for thepresence of marijuana, cocaine, opiates and a breath screen to detect the presenceof alcohol)
Inability to comprehend the consent form appropriately
Inability to cooperate with study procedures
Other specific fMRI exclusions include metal devices, clips or fragments in body (orbital xray performed if needed)
Study Design
Study Description
Connect with a study center
Hartford Hospital
Hartford, Connecticut 06106
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.